Newsroom

Newsroom

NeoGenomics Reports Revenue of $125 Million in the Second Quarter

Press Release
Read More

NeoGenomics Announces Chief Executive Officer Appointment

Press Release
Read More

NeoGenomics Schedules its Second Quarter 2022 Earnings Release for August 9, 2022

Press Release
Read More

Orphan CDx assays

Blog
Read More

MultiOmyx 101: An Introduction to Multiplexing Technology

Blog
Read More

Comprehensive Genomic Profiling (CGP) expands precision medicine’s utility

Blog
Read More

NeoGenomics Liquid Biopsy Subsidiary Inivata Announces New Data Demonstrating Clinical Potential of the RaDaR(TM) MRD Test in HR+ HER2- Breast Cancer

Press Release
Read More

NeoGenomics will be exhibiting at the 2022 ASCO Annual Meeting from June 4 – 6

Blog
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients